NCT00006357 - STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

April 30, 2001

Conditions

Endometrial CancerGastrointestinal Stromal TumorOvarian CancerSarcomaSmall Intestine Cancer

Interventions

DRUG

imatinib mesylate

Trial Locations (16)

2100

Rigshospitalet, Copenhagen

69373

Centre Leon Berard, Lyon

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-3000

U.Z. Gasthuisberg, Leuven

DK-8000

Aarhus Kommunehospital, Aarhus

DK-2730

Herlev Hospital - University Hospital of Copenhagen, Herlev

F-94805

Institut Gustave Roussy, Villejuif

1066 CX

Antoni van Leeuwenhoekhuis, Amsterdam

9713 EZ

Academisch Ziekenhuis Groningen, Groningen

2300 CA

Leiden University Medical Center, Leiden

NL-6252 HB

University Medical Center Nijmegen, Nijmegen

3075 EA

Rotterdam Cancer Institute, Rotterdam

SW3 6JJ

Royal Marsden NHS Trust, London

M20 4BX

Christie Hospital N.H.S. Trust, Manchester

NG5 1PB

Nottingham City Hospital NHS Trust, Nottingham

S1O 2SJ

Weston Park Hospital, Sheffield

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK